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from 5.3 to 38%.
[3] Neurological involvement in BD has been
Behçet's disease can affect the central nervous system.
classified into two major forms. [4] One form can be attributed to Behçet's disease (BD) is a multisystem inflammatory disorder with unknown etiology characterized by recurrent oral and genital aphthous ulcers and uveitis. Vasculitis is the major pathological feature.
[1] It was first described in 1937 by Hulusi Behçet, a Turkish dermatologist.
[2] The disease can affect the skin, joints, intestines, lungs, heart and central nervous system. Neurological involvement in BD was first reported by Knapp in 1941 [1] and it diagnosis of BD was made according to the international criteria for diagnosis of Behçet's disease.
[5] Patients were excluded from the study if they currently had any neurological symptoms or signs or if they had any history of central nervous system disorders such as cerebral infarction, hemorrhage, tumors, etc. Three patients were excluded because of positive findings in their neurological examinations. Table 1 summarizes the organ system manifestations of BD seen in our patients. The disease was found to be active in every patient at the time of the evaluation. Therapy consisted of steroids, colchicine and vitamin B preparations. Up to the time of the study, mean disease duration was 8.05±1.32 years. Methods used for the evaluation of subclinical neurological involvement were EEG, BAEP, MRI and SPECT. Findings from these were compared with those of controls.
BAEP Brainstem auditory evoked potential examination was performed on 36 patients (13 women, 23 men). The mean age of the patients was 36.39 ± 9.79 years (range 19 to 58 years). None of these patients had a history of hearing loss. BAEP was performed with a Medelec synergy EMG instrument (Oxford Instruments Medical, Inc, UK). One electrode was positioned at Cz and referred to the right (M2) and left (M1) mandibles. Click stimulus and noise were applied to the headphones at 90dB and 40dB, respectively. The click stimulus was applied at a frequency of 10 per second. Measurements were made in both ears as follows. A total of 33 patients (19 women, 14 men) underwent SPECT. In each ear, a series of 2000 stimuli was presented twice, for a Their mean age was 35.9 ± 10.04 years (range 19 to 58 years). total of 4000 stimuli per ear. For each ear, the average of these two The control group consisted of 23 women whose data were obtained trials was taken. Latencies of Waves I, III, V and I-III and III-V in a study of menstrual migraine. The mean age of this group was interwave latencies were calculated. Two neurologists evaluated 34.2 ± 5.2 years. Single photon emission computed tomography the results blindly. Our laboratory normal values were accepted as was performed using an Elscint SPX 6 gamma camera (Ashby a reference in place of a control group. According to these values, GD, UK). A parallel isolated collimator for general use with low the Wave I, III and V latencies were accepted as 1.7 ± 0.15, 3.9 energy was selected. Data were collected in a 64 x 64 matrix and ± 0.19 and 5.93 ± 0.25 respectively. between 1.5 200 m and 360-degree angles (25 seconds/degree, 6 degree intervals). The SPECT images (coronal, sagittal and axial) EEG were processed with backprojection and by MET2 filters. The Thirty patients (18 women, 12 men) underwent EEG pharmaceutical agent was 99-mTc-HMPAO. This was prepared evaluation. Their mean age was 35.6 ± 10.9 years (range 19 to by the addition 2.2 GBq (60 mCi) of Tc-99 m to the commercial 58 years). The control group consisted of 18 healthy people (12 kit (Brain SPECT, Hungary) with 0.9% saline solution to make women, 6 men) and their mean age was 37.8 ± 8.5 years. a total of 5 ml for injection. The bottle containing the preparation Electroencephalography was performed with a 21-channel digital was shaken mechanically for 10 min and the preparation was EEG machine (Nihon Kohden, Japan). Awake EEGs were used within one hour. It was injected via an intravenous port as obtained with electrodes placed according to the international 10 15 mCi per patient and the imaging was started at five minutes 20 placement system. Focal spikes, temporal spikes, polyspikes, after the injection. Two nuclear medicine specialists who had no occipital spikes, frontal spikes, multifocal spikes, generalized spike information about the patients or controls evaluated the results. wave, polyspike-wave complexes, secondary bilateral synchrony, Images were evaluated qualitatively in terms of heterogeneous slow spike waves, 6Hz spike waves, bursts of polyspikes, blood flow, focal hypoperfusions or visible asymmetries in gray photoparoxysmal response, photomyogenic response, theta and For quantitative analysis, Geretec two-dimensional software delta waves were accepted as abnormal activity. (Europe Nv, Belgium) was used to evaluate the images digitally. Numerical values were obtained for anterior frontal, posterior Statistical analyses frontal, temporal, medial occipital and lateral occipital areas. For SPSS software was used (SPSS, Chicago). The Mann-Whitney SPECT matter.
comparisons in terms of left and right sides, the value of each cerebral side was divided by that of the dominant cerebellar area.
MRI
A total of 25 patients (13 women, 12 men) underwent MRI. Scans were performed with a 0.5 Tesla (T) Vectra scanner (General Electric Medical systems,Milwaukee, USA). The images were taken at the standard position immediately after gadolinium (Gd-DTPA) injection. The patients' mean age in this group was 35.8 ± 10.39 years (19 to 58 years). The control group consisted of 20 age-and gender-matched patients (11 female, 9 male) with lumbar pain who underwent additional cranial MRI for the purpose of this study. The mean age of the control group was 30.8 ± 8.7 years. The results were evaluated by a radiologist who had no information about the patients or controls.
U test and Wilcoxon Rank-Sum W test were used. A P value of less than 0.05 was accepted as significant.
Results
A total of 49 patients with BD (30 women, 19 men) were enrolled in this prospective study. Of these 49 patients, 33 (19 women, 14 men) underwent SPECT, 25 (13 women, 12 men) underwent MRI, 36 (13 women, 23 men) underwent BAEP and 30 (18 women, 12 men) underwent EEG. Some patients thus underwent more than one type of study.
In the SPECT group, we detected abnormalities in 15 patients (45.4%) with visual evaluation of the images [ Table 2 ]. We also evaluated the images quantitatively by dividing a given hemisphere's activation value by that of the dominant cerebellar In the MRI group, abnormalities were detected in nine patients (36%, Table 3 ). The patients with BD had significantly more abnormalities on MRI than did the control group (P=0.03). In the control group, one patient had areas of gliosis around the lateral ventricles.
In the patients who underwent BAEP evaluation, no significant differences were found between their findings and the normal reference values of our laboratory.
EEGs were abnormal in 11/30 (36.6%) patients with BD [ Table  4 ]. Patients in this group had significantly more abnormalities on EEG than did healthy controls (P=0.01). No abnormalities on EEG were seen in the control group.
Discussion
All patients met the diagnostic criteria outlined by the international study group for Behçet's disease, with a positive Analysis of our data revealed significant abnormalities on MRI and EEG in patients with BD.
Although we found no significant differences between BD patients and controls on SPECT, perfusional brain disorders in patients with BD have been studied previously with SPECT. [6, 7] Brain SPECT has also been found to provide useful clinical information about cerebral cortical abnormalities in patients with neurobehçet's disease.
[8] In neurobehçet's disease brain lesions are located more commonly in the brainstem, basal ganglia and hemispheric white matter.
[9] In our study we found hypoperfusion in the basal ganglia in three patients and in the parietal, frontal, temporal or occipital regions in 13 patients. The rationale for using SPECT in this study was the possibility that detectable changes in brain perfusion might reflect brain abnormalities in BD patients who have no clinical neurological symptoms.
MRI abnormalities were significantly more frequent in our patients with BD compared to the control group. In neurobehçet's found CNS involvement in 15 of 25 patients who had simple BD. [11] Regarding brainstem atrophy, Mirsattari et al reported a patient with neurobehçet's disease and secondary progressive meningoencephalitis which remained clinically and radiologically restricted to the brainstem, but on autopsy chronic active meningoencephalomyelitis involving all levels of the CNS was found, being most marked in the brainstem. [12] For our study, the only available scanner had a main field strength of 0.5 T. Although we were able to find significant abnormalities in BD patients by using this weak magnet, more abnormalities might have been detected with a stronger system. Brainstem auditory evoked potential testing, although useful in assessing the functional integrity of the lateral acoustic pathway and in detecting severe inflammatory changes, demyelinization
